Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764711 · ClinicalTrials.gov registry record · NA
Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01764711 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 13 participants.
The verdict
NCT01764711, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study is to determine different chemical levels in the blood during a low salt diet. This study will compare normal volunteers to those with Postural Tachycardia Syndrome (POTS)
Interventions
- DRUG Cosyntropin administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01764711
The ClinicalTrials.gov registry entry for NCT01764711 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cosyntropin administration is the first listed.
NCT01764711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01764711 about?
NCT01764711 is a clinical study titled "Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)". This study is to determine different chemical levels in the blood during a low salt diet. This study will compare normal volunteers to those with Postural Tachycardia Syndrome (POTS)
What is the current status of trial NCT01764711?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT01764711?
The interventions under investigation include: Cosyntropin administration (DRUG).
Who is sponsoring clinical trial NCT01764711?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.